TDT: Difference between revisions
From haematologyetc.co.uk
(Created page with " <div style="background-color: #E0EEEE; {{round corners}} padding: 2em 2em; margin-right: 5px;"> :<span style="color:navy">'''Summary'''</span> :xxxx </div> <span style="color:navy">'''Normal expression and function'''</span> xxxxx <span style="color:navy">'''Diagnostic role'''</span> *xxxxx <span style="color:navy">'''Other relevant information:'''</span> xxxxx ---- <span style="color:navy">'''''SUMMARY TABLES'''''</span> <span style="font-...") |
No edit summary |
||
| (23 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
:<span style="color:navy">'''Summary'''</span> | :<span style="color:navy">'''Summary'''</span> | ||
: | :Terminal Deoxynucleotidyl Transferase (TdT) a nuclear cell protein expressed by most cases of acute lymphoblastic leukaemia but not by more mature cells. Expression is not fully specific however as TdT is also strongly expressed by early regenerating B-lymphocytes (haematogones) and may be expressed in acute myeloid leukaemia. | ||
| Line 14: | Line 14: | ||
<span style="color:navy">'''Normal expression and function'''</span> | <span style="color:navy">'''Normal expression and function'''</span> | ||
TdT acts is a nuclear enzyme requires for the rearrangement of the VDJ genes of heavy chain of the T-cell receptor or B-cell receptor genes during the formation of mature B and T cells. expression of tdt is therefore restricted to immature lymphoid cells in bone marrow or thymus. in regenerative marrows TdT is consistently expressed on regenerative B lymphocytes (haematogones) which may represent a large proportion of marrow cells, particularly in children. | |||
| Line 20: | Line 20: | ||
<span style="color:navy">'''Diagnostic role'''</span> | <span style="color:navy">'''Diagnostic role'''</span> | ||
* | *The most useful attribute of TdT is its loss of expression by mature cells: it is good marker of primitive cells although not always expressed | ||
*TdT is consistently expressed by acute lymphoblastic leukaemia (95%) | |||
*TdT may be weakly expressed by Burkitt lymphoma but is most often absent, expression by mature B-cell lymphomas is rarely described | |||
*TdT is emay be expressed by AML cells - mainly on less differentiated forms and those related to MDS (around 20%) | |||
*TdT is expressed by haematogones becoming lost as they mature | |||
| Line 27: | Line 30: | ||
<span style="color:navy">'''Other relevant information:'''</span> | <span style="color:navy">'''Other relevant information:'''</span> | ||
As a nuclear marker TdT requires cells to be permeabilised for detection by flow cytometry | |||
| Line 42: | Line 45: | ||
{| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;" | {| class=wikitable style="text-align: center; font-size:80%; width: 100%; height 20px;" | ||
|- | |- | ||
!colspan="8"| | !colspan="8"|'''Expression in primitive cell types'''</font> | ||
|- | |- <span style="font-size:70%"> | ||
! AML !! CMML !! B ALL !! | !AML!!CMML !!B ALL !!BL ||T ALL !!ETP ALL !!MPAL ||Hgn</span> | ||
|- | |-<span style="font-size:70%"> | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #66e0ff; color:black; font-size:90%"|5-20% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black; font-size:90%"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #004466; color:white; font-size:90%"|80-100% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #66e0ff; color:black; font-size:90%"|5-20% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #004466; color:white; font-size:90%"|80-100% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #006699; color:white; font-size:90%"|40-80% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #006699; color:white; font-size:90%"|40-80% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #004466; color:white; font-size:90%"|80-100% | ||
|- | |- | ||
|} | |} | ||
| Line 63: | Line 65: | ||
|- | |- | ||
!colspan="8"|'''Expression in mature B cell neoplasms''' | !colspan="8"|'''Expression in mature B cell neoplasms''' | ||
|- | |- <span style="font-size:70%"> | ||
! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL || LPL !! PCL | ! CLL !! MCL !!FL!! MZL !! HCL !! DLBCL || LPL !! PCL | ||
|- | |-<span style="font-size:70%"> | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|style="width: 12.5%; background: | |style="width: 12.5%; background: #E6FAFF; color:black"|<5% | ||
|- | |- | ||
|} | |} | ||
| Line 95: | Line 95: | ||
|} | |} | ||
---- | ---- | ||
Latest revision as of 21:34, 4 July 2023
- Summary
- Terminal Deoxynucleotidyl Transferase (TdT) a nuclear cell protein expressed by most cases of acute lymphoblastic leukaemia but not by more mature cells. Expression is not fully specific however as TdT is also strongly expressed by early regenerating B-lymphocytes (haematogones) and may be expressed in acute myeloid leukaemia.
Normal expression and function
TdT acts is a nuclear enzyme requires for the rearrangement of the VDJ genes of heavy chain of the T-cell receptor or B-cell receptor genes during the formation of mature B and T cells. expression of tdt is therefore restricted to immature lymphoid cells in bone marrow or thymus. in regenerative marrows TdT is consistently expressed on regenerative B lymphocytes (haematogones) which may represent a large proportion of marrow cells, particularly in children.
Diagnostic role
- The most useful attribute of TdT is its loss of expression by mature cells: it is good marker of primitive cells although not always expressed
- TdT is consistently expressed by acute lymphoblastic leukaemia (95%)
- TdT may be weakly expressed by Burkitt lymphoma but is most often absent, expression by mature B-cell lymphomas is rarely described
- TdT is emay be expressed by AML cells - mainly on less differentiated forms and those related to MDS (around 20%)
- TdT is expressed by haematogones becoming lost as they mature
Other relevant information:
As a nuclear marker TdT requires cells to be permeabilised for detection by flow cytometry
SUMMARY TABLES
Note The colour and % refer to the proportion of cases expressing the marker. Additional comments on strength, or site of expression (if relevant) are given below the table. For full details of key click here. For further information about a particular disease state click <I> adjacent to the condition name
| Expression in primitive cell types | |||||||
|---|---|---|---|---|---|---|---|
| AML | CMML | B ALL | BL | T ALL | ETP ALL | MPAL | Hgn |
| 5-20% | <5% | 80-100% | 5-20% | 80-100% | 40-80% | 40-80% | 80-100% |
| Expression in mature B cell neoplasms | |||||||
|---|---|---|---|---|---|---|---|
| CLL | MCL | FL | MZL | HCL | DLBCL | LPL | PCL |
| <5% | <5% | <5% | <5% | <5% | <5% | <5% | <5% |
| Expression in mature T cell neoplasms* | ||||||
|---|---|---|---|---|---|---|
| ATLL | CTCL/Sezary | T-PLL | T-LGL | NK-LGL | ||
| ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ||